NCT00707525
Completed
Phase 4
Incidence of EmbyoO Aneuploidies in Natural Versus Stimulated Cycles in the Same Women.
Instituto Valenciano de Infertilidad, IVI VALENCIA1 site in 1 countryFebruary 2008
ConditionsEmbryo Aneuploidies
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Embryo Aneuploidies
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA
- Locations
- 1
- Primary Endpoint
- Embryo aneuploidies
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
There is a considerable concern about the effects of controlled ovarian hyperstimulation (COH) for In Vitro Fertilization- Embryo Transfer (IVF-ET) on embryo quality and on the incidence of chromosomal abnormalities in oocytes and embryos.
The main question remaining is if COH may increase the aneuploidies rate in young and healthy women. Therefore, the primary endpoint of the present study is to analyse the incidence of chromosomal abnormalities in this group of patients (oocyte donors), either in oocytes obtained after a natural cycle or in those retrieved after a COH cycle. To get rid of the male factor influence, donated sperm will be used.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 to 35 years old.
- •BMI: 18-25Kg/m2
- •Regular menstrual cycles
- •Normal kariotype
- •No previous controlled ovarian hyperstimulation (COH) treatments.
Exclusion Criteria
- •Endometriosis
- •Policystic ovarian syndrome
- •Recurrent miscarriages.
- •Recipient Inclusion Criteria
- •Aged until 45 years old
- •No systemic diseases
- •Following egg and sperm donation treatment.
- •Recipient exclusion criteria:
- •Uterine disease (polyps, myomas, mullerian defects)
- •Recurrent miscarriages.
Outcomes
Primary Outcomes
Embryo aneuploidies
Time Frame: 2 cycles
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 4
Comparing Coasting by Withholding GnRH Agonist With GnRH AntagonistIn Vitro FertilizationNCT01347268Shin Kong Wu Ho-Su Memorial Hospital120
Unknown
Not Applicable
CuMulativE Live bIrth Rate of Patients at High Risk of OHSS After Freeze-all Embryos at Cleavage or blAstocyst StageInfertilityNCT03817060Université Libre de Bruxelles128
Completed
Not Applicable
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and GonadotropinInfertilityBreast CancerNCT01403688University of Kansas9
Completed
Not Applicable
Controlled Ovarian Stimulation by HP-hMG for IVF / ICSI Cycles: Study on Ovarian Hyper Stimulation Syndrome in a Cohort of Women From 18 to 36 Years Old.Ovarian Hyperstimulation Syndrome (OHSS)NCT01703728Ferring Pharmaceuticals455
Completed
Phase 4
NATural Ovarian StimulationInfertilityNCT02892942Assistance Publique - Hôpitaux de Paris129